Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VRVg-2 rabies vaccine in simulated post-exposure regimen
NCT03965962Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2019
- Primary completion
- Dec 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rabies vaccine serum-free vero cell in rabies, sponsored by Sanofi. Started Jul 2019; status: completed.
02
Drugs
rabies vaccine serum-free vero cell
03
Conditions
rabies
Beyond the preview
Go deeper on NCT03965962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03965962.